BUSPAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Buspar, and when can generic versions of Buspar launch?
Buspar is a drug marketed by Bristol Myers Squibb and is included in two NDAs.
The generic ingredient in BUSPAR is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Buspar
A generic version of BUSPAR was approved as buspirone hydrochloride by IMPAX LABS INC on March 28th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUSPAR?
- What are the global sales for BUSPAR?
- What is Average Wholesale Price for BUSPAR?
Summary for BUSPAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 20 |
Patent Applications: | 646 |
DailyMed Link: | BUSPAR at DailyMed |
Recent Clinical Trials for BUSPAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Spaulding Rehabilitation Hospital | Phase 2 |
University of Louisville | Early Phase 1 |
National Institute of Neurological Disorders and Stroke (NINDS) | Early Phase 1 |
US Patents and Regulatory Information for BUSPAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-001 | Dec 20, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | TABLET;ORAL | 018731-003 | Apr 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-004 | Dec 20, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | TABLET;ORAL | 018731-004 | Apr 22, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BUSPAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | TABLET;ORAL | 018731-003 | Apr 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | TABLET;ORAL | 018731-003 | Apr 22, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | TABLET;ORAL | 018731-002 | Sep 29, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | BUSPAR | buspirone hydrochloride | CAPSULE;ORAL | 021190-001 | Dec 20, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BUSPAR
See the table below for patents covering BUSPAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S6357402 | ⤷ Sign Up | |
Australia | 775591 | ⤷ Sign Up | |
Malaysia | 7700151 | HETEROCYCLIC AZASPIROALKANE DIONES | ⤷ Sign Up |
Mexico | PA02007003 | METODO PARA LA ANSIEDAD. (ANXIETY METHOD.) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |